Neurocrine Biosciences, Inc. (NBIX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:13AM EDT. Market open.
| Previous close | 138.97 |
| Open | 139.37 |
| Bid | 138.35 x 100 |
| Ask | 139.13 x 300 |
| Day's range | 137.68 - 139.37 |
| 52-week range | 89.04 - 148.37 |
| Volume | |
| Avg. volume | 885,569 |
| Market cap | 13.964B |
| Beta (5Y monthly) | 0.28 |
| PE ratio (TTM) | 56.21 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 29 Dec 1995 |
| 1y target est | N/A |
- Investor's Business Daily
Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?
Top-notch biotech stock Neurocrine surged Tuesday after analysts suggested the company's depression treatment could rival ketamine.
- Zacks
Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
Neurocrine (NBIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Insider Monkey
10 Best Performing Biotech ETFs in 2024
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]
© 2024 Yahoo. All rights reserved.